Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.
Saved in:
| Title: | Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy. |
|---|---|
| Authors: | Tandaric L; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway., Bjørge L; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway., Lode MR; Precision Oncology Research Group, Department of Clinical Science, University of Bergen, Norway.; Kinn Therapeutics AS, Bergen, Norway., Torkildsen CF; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Stavanger University Hospital, Stavanger, Norway.; Department of Obstetrics and Gynecology, Heidelberg University Hospital, Germany., Aehnlich P; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Precision Oncology Research Group, Department of Clinical Science, University of Bergen, Norway., Elnour R; Department of Clinical Medicine, Centre for Cancer Biomarkers CCBIO and Gade Laboratory of Pathology, University of Bergen, Norway., Costea DE; Department of Clinical Medicine, Centre for Cancer Biomarkers CCBIO and Gade Laboratory of Pathology, University of Bergen, Norway.; Department of Pathology, Laboratory Clinic, Haukeland University Hospital, Bergen, Norway., Akslen LA; Department of Clinical Medicine, Centre for Cancer Biomarkers CCBIO, Section for Pathology, University of Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Thomsen LCV; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.; Department of Health Registry Research and Development, Norwegian Institute of Public Health, Oslo, Norway., McCormack E; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Norway.; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway., Kleinmanns K; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway. |
| Source: | Molecular oncology [Mol Oncol] 2026 Mar 14. Date of Electronic Publication: 2026 Mar 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41830513 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tandaric+L%22">Tandaric L</searchLink>; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Bjørge+L%22">Bjørge L</searchLink>; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Lode+MR%22">Lode MR</searchLink>; Precision Oncology Research Group, Department of Clinical Science, University of Bergen, Norway.; Kinn Therapeutics AS, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Torkildsen+CF%22">Torkildsen CF</searchLink>; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Stavanger University Hospital, Stavanger, Norway.; Department of Obstetrics and Gynecology, Heidelberg University Hospital, Germany.<br /><searchLink fieldCode="AU" term="%22Aehnlich+P%22">Aehnlich P</searchLink>; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Precision Oncology Research Group, Department of Clinical Science, University of Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Elnour+R%22">Elnour R</searchLink>; Department of Clinical Medicine, Centre for Cancer Biomarkers CCBIO and Gade Laboratory of Pathology, University of Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Costea+DE%22">Costea DE</searchLink>; Department of Clinical Medicine, Centre for Cancer Biomarkers CCBIO and Gade Laboratory of Pathology, University of Bergen, Norway.; Department of Pathology, Laboratory Clinic, Haukeland University Hospital, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Akslen+LA%22">Akslen LA</searchLink>; Department of Clinical Medicine, Centre for Cancer Biomarkers CCBIO, Section for Pathology, University of Bergen, Norway.; Department of Pathology, Haukeland University Hospital, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Thomsen+LCV%22">Thomsen LCV</searchLink>; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.; Department of Health Registry Research and Development, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22McCormack+E%22">McCormack E</searchLink>; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Norway.; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Kleinmanns+K%22">Kleinmanns K</searchLink>; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Norway.; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2026 Mar 14. <i>Date of Electronic Publication: </i>2026 Mar 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41830513 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/1878-0261.70231 Languages: – Code: eng Text: English Titles: – TitleFull: Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tandaric L – PersonEntity: Name: NameFull: Bjørge L – PersonEntity: Name: NameFull: Lode MR – PersonEntity: Name: NameFull: Torkildsen CF – PersonEntity: Name: NameFull: Aehnlich P – PersonEntity: Name: NameFull: Elnour R – PersonEntity: Name: NameFull: Costea DE – PersonEntity: Name: NameFull: Akslen LA – PersonEntity: Name: NameFull: Thomsen LCV – PersonEntity: Name: NameFull: McCormack E – PersonEntity: Name: NameFull: Kleinmanns K IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 03 Text: 2026 Mar 14 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1878-0261 Titles: – TitleFull: Molecular oncology Type: main |
| ResultId | 1 |
